Smartleaf Asset Management LLC lifted its position in shares of Rentokil Initial plc (NYSE:RTO – Free Report) by 486.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,942 shares of the company’s stock after purchasing an additional 1,611 shares during the period. Smartleaf Asset Management LLC’s holdings in Rentokil Initial were worth $49,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Valley Wealth Managers Inc. acquired a new position in shares of Rentokil Initial during the third quarter worth $29,000. Assetmark Inc. acquired a new position in shares of Rentokil Initial during the third quarter worth $36,000. Cape Investment Advisory Inc. lifted its position in shares of Rentokil Initial by 65.2% during the fourth quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company’s stock worth $38,000 after purchasing an additional 594 shares in the last quarter. Sunbelt Securities Inc. lifted its position in shares of Rentokil Initial by 30.1% during the third quarter. Sunbelt Securities Inc. now owns 1,737 shares of the company’s stock worth $43,000 after purchasing an additional 402 shares in the last quarter. Finally, CENTRAL TRUST Co lifted its position in shares of Rentokil Initial by 15,208.3% during the fourth quarter. CENTRAL TRUST Co now owns 1,837 shares of the company’s stock worth $47,000 after purchasing an additional 1,825 shares in the last quarter. 9.91% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several analysts recently issued reports on RTO shares. Citigroup raised shares of Rentokil Initial to a “strong-buy” rating in a report on Friday, December 13th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Rentokil Initial in a report on Friday. Four equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.
Rentokil Initial Trading Down 5.0 %
RTO opened at $21.80 on Tuesday. The stock has a market capitalization of $11.00 billion, a PE ratio of 14.43, a P/E/G ratio of 7.95 and a beta of 1.14. The firm’s fifty day moving average price is $24.80 and its 200 day moving average price is $25.71. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.04 and a quick ratio of 0.96. Rentokil Initial plc has a 12-month low of $21.69 and a 12-month high of $34.07.
Rentokil Initial Dividend Announcement
The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 4th will be given a dividend of $0.3825 per share. This represents a dividend yield of 2.4%. The ex-dividend date of this dividend is Friday, April 4th. Rentokil Initial’s dividend payout ratio is presently 23.84%.
Rentokil Initial Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Articles
- Five stocks we like better than Rentokil Initial
- What is the Shanghai Stock Exchange Composite Index?
- How to Protect Your Portfolio When Inflation Is Rising
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.